199 related articles for article (PubMed ID: 26763474)
1. Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance.
Korytny A; Riesenberg K; Saidel-Odes L; Schlaeffer F; Borer A
Infect Dis (Lond); 2016; 48(6):428-31. PubMed ID: 26763474
[TBL] [Abstract][Full Text] [Related]
2. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
Endimiani A; Luzzaro F; Brigante G; Perilli M; Lombardi G; Amicosante G; Rossolini GM; Toniolo A
Antimicrob Agents Chemother; 2005 Jul; 49(7):2598-605. PubMed ID: 15980325
[TBL] [Abstract][Full Text] [Related]
3. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes.
Cohen-Nahum K; Saidel-Odes L; Riesenberg K; Schlaeffer F; Borer A
Infection; 2010 Feb; 38(1):41-6. PubMed ID: 19998053
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Proteus mirabilis.
Kurihara Y; Hitomi S; Oishi T; Kondo T; Ebihara T; Funayama Y; Kawakami Y
J Infect Chemother; 2013 Oct; 19(5):799-805. PubMed ID: 23371453
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.
Tumbarello M; Trecarichi EM; Fiori B; Losito AR; D'Inzeo T; Campana L; Ruggeri A; Di Meco E; Liberto E; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2012 Jun; 56(6):3224-31. PubMed ID: 22450979
[TBL] [Abstract][Full Text] [Related]
6. Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.
Tsai HY; Chen YH; Tang HJ; Huang CC; Liao CH; Chu FY; Chuang YC; Sheng WH; Ko WC; Hsueh PR
Diagn Microbiol Infect Dis; 2014 Nov; 80(3):222-6. PubMed ID: 25139843
[TBL] [Abstract][Full Text] [Related]
7. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
Chen CY; Chen YH; Lu PL; Lin WR; Chen TC; Lin CY
J Microbiol Immunol Infect; 2012 Jun; 45(3):228-36. PubMed ID: 22572004
[TBL] [Abstract][Full Text] [Related]
8. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
9. A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres.
Adler A; Baraniak A; Izdebski R; Fiett J; Gniadkowski M; Hryniewicz W; Salvia A; Rossini A; Goossens H; Malhotra S; Lerman Y; Elenbogen M; Carmeli Y;
Clin Microbiol Infect; 2013 Feb; 19(2):E51-8. PubMed ID: 23210906
[TBL] [Abstract][Full Text] [Related]
10. The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.
Ahn JY; Ann HW; Jeon Y; Ahn MY; Oh DH; Kim YC; Kim EJ; Song JE; Jung IY; Kim MH; Jeong W; Ku NS; Jeong SJ; Choi JY; Yong D; Song YG; Kim JM
BMC Infect Dis; 2017 May; 17(1):327. PubMed ID: 28468622
[TBL] [Abstract][Full Text] [Related]
11. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
Yayan J; Ghebremedhin B; Rasche K
BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
[TBL] [Abstract][Full Text] [Related]
12. Proteus species bloodstream infections: Comparative epidemiology of three species.
Laupland KB; Edwards F; Harris PNA
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116286. PubMed ID: 38574445
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France.
Siebor E; Neuwirth C
J Antimicrob Chemother; 2013 Aug; 68(8):1750-6. PubMed ID: 23580563
[TBL] [Abstract][Full Text] [Related]
14. Influx of multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection.
Pop-Vicas A; Tacconelli E; Gravenstein S; Lu B; D'Agata EM
Infect Control Hosp Epidemiol; 2009 Apr; 30(4):325-31. PubMed ID: 19220162
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
17. Primary and Secondary Bacteremia Caused by
Kwiecińska-Piróg J; Skowron K; Gospodarek-Komkowska E
Pol J Microbiol; 2018; 67(4):471-478. PubMed ID: 30550233
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
19. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
[TBL] [Abstract][Full Text] [Related]
20. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
Schultz E; Haenni M; Mereghetti L; Siebor E; Neuwirth C; Madec JY; Cloeckaert A; Doublet B
J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
